ArticleUnited European gastroenterology journal2019

Cost-of-illness of inflammatory bowel disease patients treated with anti-tumour necrosis factor: A French large single-centre experience.

Jean Lawton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.